![[LOGO] The Belgian Menopause Society](img/logo.png){kind=logo}
Topics
Update in Postmenopausal Osteoporosis.
- Premenopausal osteoporosis
- Interest of health economic analyses for the management of post-menopausal osteoporosis
- Cancer treatment-induced bone loss in breast cancer
- Preventing bone loss by targeting RANKL - a different approach
- Denosumab to reduce fracture risk in postmenopausal women with osteoporosis
The Perimenopause
- Contraceptive needs and Regimes in the peri-menopause.
- When peri-menopausal women want to concieve : dreams and facts
- Management of abnormal uterine bleeding during menopausal transition.
- Development and future of "selective progesterone receptor modulators".
- Management of climateric sypmtoms in the peri-menopausal women.
The Menopause Mythology : having sex after fifty : Men love their drug, are women still waiting for theirs?
- Diagnostic process of female sexual dysfunction
- Medical treatment of hypoactive sexual desire disorder
- Having sex after 50 : men and women's differences.
- Sexual and psychological functioning in women with gynaecologic cancer.
Screening and Prevention in a menopause consultation.
- Which tests are needed and useful?
- Should we screen for metabolic syndrome?
- How effective and safe are complementary and alternative medications: an evidence based answer.
- Prevention: How to successfully motivate your patient!
- Breast cancer prevention; What should be done?
- Colorectal cancer prevention: What should be done?
Reproductive endocrinology (including placental hormones)
Pressconference 23/09/2014
- Perceptions erronées chez les femmes belges autour de la ménopause et son traitement
- Misvattingen onder Belgische vrouwen over menopauze en zijn behandelingen
- Axelles Pintiaux
- Birgit Van Hoorde
- Prof Depypere and Dr Desreux
- Serge Rozenberg
Premature Ovarian Failure - Primary Ovarian Insufficiency
- Etiologies of primary ovarian insuddiciency.
- How insufficient is this patient with "Primary ovarian Insufficancy", value of measurements and prognosis?
- How to prevent primary ovarian insufficienty-related fertility?
- Long term risks and management of Primary ovarian Insufficiency. TRratment of Primary ovarian insufficiency.
- Breast cancer & fertility. Do we provide the good information?
Post IMS Prague : Update on menopause hormone therapy (MHT).
- Risk factors for breast cancer
- Other herbal preparations for menopause
- IMS 2016 news
- The evidence base for HRT : What can we believe?
- Report of IMS Praha
Post EMAS meeting: New data on menopause treatment in Europe
- News on Cancer, Menopause and HRT use
- News on cardio, cognitive and osteoporosis
- News on Menopause and metabolism
New data and evidence in osteoporosis.
- Antiresorptive therapy: when to start? When to have a drug Holiday?
- Osteoporosis management in cancer patients?
- Is there again/still a place for Menopause Hormone Therapy for osteoporosis treatment?
- General Assembly
- Review of important papers and data in 2017
- Review of important papers and data in 2017
New and alternative regimens for hot flushes
- Introduction
- Non medical amternative treatment of vasomotor symptoms
- Non hormonal medical treatment of vasomotor symptoms
- Cognitive behavior and vasomotor symptoms
- What is a tissue selective estrogen complex (TSEC)? How does it work?
- Clinical overview of conjugated estrogens/bazedoxifene (CE/BZA).
- Poster Prices 2015 Winner
- Poster Prices 2015 Winner
- Poster Prices 2015
- Poster Prices 2015
Neurological disorders, women, menopause and hormones.
- Alzheimer's Disease : Why are women more affected?
- PRevention of alzheimer
- Treatment of dementia and Alzheimer : effects/risks of other medication on cognition, dementia, Alzheimer
- Alzheimer's disease, menopause and hormone replacement therapy
Neglected aspects of menopause
- Menopause, menopause treatment and urological sypmtoms
- Histology of vaginal wall in women with pelvic organ prolapse
- Management of pelvic organ prolapse
- Pitfalls of vulvovaginal pathologies
- Cervixpathology after menopause
Menopause and Metabolism
- Obestity and menopause
- Type II diabetes : an pandemia. up to date strategies
- Nutrition and menopause
- Management of dyslipidemia in postmenopausal women
- Guidelines for management of dislipidimia
Menopause and Brain
- Ultrasound assessment of the intima and media layers in the carotid arteries in peri- and postmenopausal women
- Sleep disorders and Menopause
- Is fibromyalgia part of climateric syndrome?
- Prevention of cognitive aging
- Dementia and hormones
Menopausal management of complex cases
Important information of the International Menopause Society Meeting in Madrid.
Imaging in the post-menopausal woman.
- Breast density : a biomarker of breast cancer risk.
- Which indication for Breast MRI?
- Use of pelvic ultrasound screening in postmenopausal women.
Hyperandrogenism, polycystic ovaries and obestity after menopause : Meet the experts.
- How should postmenopausal androgen excess be evaluated?
- Polycystic ovaries - beyond menopause
- BMI and Breast Cancer outcome
- Causes of virilization in postmenopausal women : cas report
- Management of hyperanfrogenism at the menopause
How to manage a Menopause Clinic
- Alternative treatment of hot flushes - from an evidence based perspective
- Update in breast cancer screening for postmenopausal patientes: Which screening for which patient?
- Update on cardiovascular disease in postmenopausal patients
- Which endometrial surveillance for postmenopausal patients
Hormones and cancer: an update.
- Quality of life and Menopause treatment after pelvic cancers (endometrium, ovarian an cervix)
- Which SERMS and aromatase onhibitors should be given to whom and for how long?
- Is there a place for Menopause Hormone Therapy in High risk breast cancer patients (BRCA1 & 2)
- Medical Risk reducing strategies for breast cancer
- Surgical Risk reducing strategies for breast cancer
- Androgens ans SPRMS and breast cancer
Debates on osteoporosis management.
- Risk assessments in 2008.
- Management of the young osteoporotic woman.
- Debate: place of HRT in bone health?
- Safety of Biphosphonates: for whom and for how long?
- Once yearly Aclasta for the management of osteoporosis.
Cardiovascular risk in women revisited.
- Homeostasis, Thrombosis risk and hormone therapy.
- Postmenopausal hormone therapy and cardiovascular mortality risk.
Cardiovascular disease in postmenopausal women and hormone therapy NEW INSIGHTS
- Cardiovascular disease in postmenopausal women and men: differences in presentation, treatment and outcome.
- Gender differences in risk factors and their control: smoking, hypertension and hypercholesterolaemia.
- Timing of initiation of hormone therapy and cardiovascular disease.
Cancer in women after menopause.
- Gender difference in incidence, survival and mortality for principal cancers.
- Women and lung cancer: the influence of reproductive factors?
- Endometrium protection and progestins: How much, which ones, and for how long? A reappraisal.
- Gynaecological uses of a new class of steroids: the selective progesterone receptor modulators.